A comparison of pharmacokinetic models of dynamic contrast enhanced MRI

被引:14
|
作者
Srikanchana, R [1 ]
Thomasson, D [1 ]
Choyke, P [1 ]
Dwyer, A [1 ]
机构
[1] NCI, Bethesda, MD 20892 USA
关键词
D O I
10.1109/CBMS.2004.1311740
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Dynamic Contrast Enhanced MRI (DCE-MRI) is often employed as an indicator of drug activity in clinical trials of angiogenic inhibitors. The data obtained with DCE-MRI is reported semi quantitatively using parameters derived from pharmacokinetic models. Most MPI kinetic models were developed from Nuclear Medicine quantitative studies but the limitations of MRI dictated specific modifications. A number of these MRI models are in current use. In this work, we review several pharmacokinetic models used in DCE-MRI in order to determine the most appropriate model to assess tumor angiogenesis. These models are compared with respect to their physiological appropriateness; compartmental analysis; initial and boundary conditions; and clinically relevant output parameters.
引用
收藏
页码:361 / 366
页数:6
相关论文
共 50 条
  • [1] Statistical comparison of dynamic contrast-enhanced MRI pharmacokinetic models in human breast cancer
    Li, Xia
    Welch, E. Brian
    Chakravarthy, A. Bapsi
    Xu, Lei
    Arlinghaus, Lori R.
    Farley, Jaime
    Mayer, Ingrid A.
    Kelley, Mark C.
    Meszoely, Ingrid M.
    Means-Powell, Julie
    Abramson, Vandana G.
    Grau, Ana M.
    Gore, John C.
    Yankeelov, Thomas E.
    [J]. MAGNETIC RESONANCE IN MEDICINE, 2012, 68 (01) : 261 - 271
  • [2] Suitability of Pharmacokinetic Models for Dynamic Contrast-Enhanced MRI of Abdominal Aortic Aneurysm Vessel Wall: A Comparison
    Nguyen, V. Lai
    Kooi, M. Eline
    Backes, Walter H.
    van Hoof, Raf H. M.
    Saris, Anne E. C. M.
    Wishaupt, Mirthe C. J.
    Hellenthal, Femke A. M. V. I.
    van der Geest, Rob J.
    Kessels, Alfons G. H.
    Schurink, Geert Willem H.
    Leiner, Tim
    [J]. PLOS ONE, 2013, 8 (10):
  • [3] A comparison of pharmacokinetic modeling of dynamic contrast enhanced MRI for evaluating response in angiogenic inhibitor therapy
    Thomasson, D
    Choyke, P
    Dwyer, A
    Yao, J
    [J]. JOURNAL OF IMMUNOTHERAPY, 2003, 26 (06): : S26 - S26
  • [4] Classic models for dynamic contrast-enhanced MRI
    Sourbron, Steven P.
    Buckley, David L.
    [J]. NMR IN BIOMEDICINE, 2013, 26 (08) : 1004 - 1027
  • [5] Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate
    Huisman, HJ
    Engelbrecht, MR
    Barentsz, JO
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2001, 13 (04) : 607 - 614
  • [6] Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI
    Su, Min-Ying
    Baik, Hyun-Man
    Yu, Hon J.
    Chen, Jeon-hor
    Mehta, Rita S.
    Nalcioglu, Orhan
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2006, 5 (04) : 401 - 410
  • [7] Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen Content
    Kamimura, Kiyohisa
    Nakajo, Masanori
    Bohara, Manisha
    Nagano, Daigo
    Fukukura, Yoshihiko
    Fujio, Shingo
    Takajo, Tomoko
    Tabata, Kazuhiro
    Iwanaga, Takashi
    Imai, Hiroshi
    Nickel, Marcel Dominik
    Yoshiura, Takashi
    [J]. CANCERS, 2021, 13 (15)
  • [8] Comparison of Dynamic Contrast-Enhanced MRI and Dynamic Contrast-Enhanced CT Biomarkers in Bladder Cancer
    Naish, J. H.
    McGrath, D. M.
    Bains, L. J.
    Passera, K.
    Roberts, C.
    Watson, Y.
    Cheung, S.
    Taylor, M. B.
    Logue, J. P.
    Buckley, D. L.
    Tessier, J.
    Young, H.
    Waterton, J. C.
    Parker, G. J. M.
    [J]. MAGNETIC RESONANCE IN MEDICINE, 2011, 66 (01) : 219 - 226
  • [9] Comparison of Denoising Methods On Dynamic Contrast-Enhanced MRI
    He, R.
    Ding, Y.
    Wahid, K.
    Mohamed, A.
    McDonald, B.
    Naser, M.
    Wang, J.
    Hutcheson, K.
    Fuller, C.
    Lai, S.
    [J]. MEDICAL PHYSICS, 2022, 49 (06) : E777 - E778
  • [10] Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria
    Vivoda Tomsic, Martina
    Bisdas, Sotirios
    Kovac, Viljem
    Sersa, Igor
    Popovic, Katarina Surlan
    [J]. CANCER IMAGING, 2019, 19 (1):